Nobilis files IND for trial to study drug-device PTSD therapy

Nobilis Therapeutics said yesterday that it filed an investigational new drug application with the FDA to kick off a Phase IIb trial of its NBTX-001 drug-device PTSD therapy.
The Portland, Ore.-based company is developing a portable inhalation device designed to deliver a xenon gas mixture.
Get the full story at our sister site, Drug Delivery Business News.
The post Nobilis files IND for trial to study drug-device PTSD therapy appeared first on MassDevice.

Source: Mass Device - January 8, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Featured Food & Drug Administration (FDA) Neurological Pharmaceuticals nobilistherapeutics Source Type: news